Multivitamin supplementation in HIV infected adults initiating antiretroviral therapy in Uganda: The protocol for a randomized double blinded placebo controlled efficacy trial

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Guwatudde, David ^a   Ezeamama, Amara E ^b   Bagenda, Danstan ^a   Kyeyune, Rachel ^a   Wabwire Mangen, Fred ^a   Wamani, Henry ^a   Mugusi, Ferdinand ^c   Spiegelman, Donna ^b   Wang, Molin ^b   Manabe, Yukari C ^a,d   Fawzi, Wafaie W ^b  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HAART; HIV infected adults; Micronutrient supplementation; Nutrition; Randomized double blind placebo controlled trial; Sub Saharan Africa; Trial protocol; Uganda

Indexed keywords

ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; MULTIVITAMIN; NICOTINIC ACID; PLACEBO; PYRIDOXINE; RIBOFLAVIN; THIAMINE;

ADULT; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIARRHEA; DIETARY INTAKE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; UGANDA; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY WEIGHT; CLINICAL PROTOCOLS; DIET; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PLACEBOS; QUALITY OF LIFE; TREATMENT OUTCOME; UGANDA; VITAMINS; YOUNG ADULT;

EID: 84868709149     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-304     Document Type: Article

References (22)

1. Coyne-Meyers K, Trombley LE. A review of nutrition in human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Nutr Clin Pract 2004, 19(4):340-355. 10.1177/0115426504019004340, 16215125.
2. Beisel WR. Single nutrients and immunity. Am J Clin Nutr 1982, 35(2 Suppl):417-468.
3. Dreizen S. Nutrition and the immune response - a review. Int J Vitam Nutr Res 1979, 49(2):220-228.
4. Jiamton S, et al. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS 2003, 17(17):2461-2469. 10.1097/00002030-200311210-00008, 14600517.
5. Fawzi WW, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998, 351(9114):1477-1482. 10.1016/S0140-6736(98)04197-X, 9605804.
6. Allard JP, et al. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. AIDS 1998, 12(13):1653-1659. 10.1097/00002030-199813000-00013, 9764785.
7. McComsey G, et al. Effect of antioxidants on glucose metabolism and plasma lipids in HIV-infected subjects with lipoatrophy. J Acquir Immune Defic Syndr 2003, 33(5):605-607. 10.1097/00126334-200308150-00009, 12902805.
8. Batterham M, et al. A preliminary open label dose comparison using an antioxidant regimen to determine the effect on viral load and oxidative stress in men with HIV/AIDS. Eur J Clin Nutr 2001, 55(2):107-114. 10.1038/sj.ejcn.1601124, 11305623.
9. Spada C, et al. An evaluation of antiretroviral therapy associated with alpha-tocopherol supplementation in HIV-infected patients. Clin Chem Lab Med 2002, 40(5):456-459.
10. de Souza Junior O, et al. alpha-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability. Clin Chem Lab Med 2005, 43(4):376-382.
11. Jaruga P, et al. Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. Free Radic Biol Med 2002, 32(5):414-420. 10.1016/S0891-5849(01)00821-8, 11864781.
12. Kaiser JD, et al. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial. J Acquir Immune Defic Syndr 2006, 42(5):523-528. 10.1097/01.qai.0000230529.25083.42, 16868496.
13. Lopez O, et al. Could antioxidant supplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia?. Biomed Pharmacother 2003, 57(3-4):113-116.
14. Mast TC, et al. Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care 2004, 16(1):81-94. 10.1080/09540120310001633994, 14660146.
15. Grinsztejn B, et al. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil. J Acquir Immune Defic Syndr 2007, 45(5):515-520. 10.1097/QAI.0b013e3180decb6a, 17558332.
16. Coetzee D, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004, 18(6):887-895. 10.1097/00002030-200404090-00006, 15060436.
17. Kamya MR, et al. Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2007, 46(2):187-193. 10.1097/QAI.0b013e31814278c0, 17693883.
18. Seyler C, et al. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Cote d'Ivoire. Antivir Ther 2003, 8(5):385-393.
19. Stangl AL, et al. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care 2007, 19(5):626-636. 10.1080/09540120701203915, 17505923.
20. Rosner B. Fundamentals of Biostatistics 2000, Pacific Grove: Duxbury Press, 5.
21. Drain PK, et al. Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am J Clin Nutr 2007, 85(2):333-345.
22. Isanaka S, et al. Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial. JAMA 2012, 308(15):1535-1544. 10.1001/jama.2012.13083, 23073950.